Novel spiropiperidine-based stearoyl-CoA desaturase-1 inhibitors: Identification of 1′-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4′-piperidine]
摘要:
Cyclization of the benzoylpiperidine in lead compound 2 generated a series of novel and highly potent spiropiperidine-based stearoyl-CoA desaturase (SCD)-1 inhibitors. Among them, 1'-{6-[5-(pyridin-3-ylmethyl)-1,3,4-oxadiazol-2-yl]pyridazin-3-yl}-5-(trifluoromethyl)-3,4-dihydrospiro[chromene-2,4'-piperidine] (19) demonstrated the most powerful inhibitory activity against SCD-1, not only in vitro but also in vivo (C57BL/6 J mice). With regard to the pharmacological evaluation, 19 showed powerful reduction of the desaturation index in the plasma of C57BL/6 J mice on a non-fat diet after a 7-day oral administration (q.d.) without causing notable abnormalities in the eyes or skin up to the highest dose (3 mg/kg) in our preliminary analysis. (C) 2009 Elsevier Ltd. All rights reserved.
SPIRO DERIVATIVES FOR THE MODULATION OF STEAROYL-COA DESATURASE
申请人:Dales Natalie
公开号:US20120010135A1
公开(公告)日:2012-01-12
The present invention provides spiro derivatives that modulate the activity of stearoyl-CoA desaturase. Methods of using such derivatives to modulate the activity of stearoyl-CoA desaturase and pharmaceutical compositions comprising such derivatives are also encompassed.
[EN] SPIRO DERIVATIVES FOR THE MODULATION OF STEAROYL-COA DESATURASE<br/>[FR] DÉRIVÉS SPIRO POUR LA MODULATION DE LA STÉAROYL-COA DÉSATURASE
申请人:NOVARTIS AG
公开号:WO2010112520A1
公开(公告)日:2010-10-07
The present invention provides spiro derivatives that modulate the activity of stearoyl- CoA desaturase. Methods of using such derivatives to modulate the activity of stearoyl- CoA desaturase and pharmaceutical compositions comprising such derivatives are also encompassed.